University of Washington Department of Global Health

Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

Retrieved on: 
Wednesday, November 8, 2023
University of Washington Department of Global Health, Stanford University, Bio, Infection, Therapy, Viral, Biotechnology, Herpes simplex virus, BS, MD, Publication, Doctor of Philosophy, Gilead Sciences, Sofosbuvir, University, Assembly, HCV, Virology, Chemistry, Patient, HDV, HBV, SAN, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, has joined the company as chief medical officer. Dr. Gaggar is an infectious disease specialist and seasoned executive whose experience has focused on the development of new therapies in viral diseases including chronic hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) infections.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, has joined the company as chief medical officer.
  • “We are excited to have Dr. Gaggar join Assembly Bio’s leadership team at an incredibly important time for the organization,” said Jason Okazaki, chief executive officer and president.
  • Dr. Gaggar was a clinical fellow in infectious diseases at the University of California, San Francisco, where he also served as chief resident.
  • He received his MD and PhD from the University of Washington and his BS in chemistry from Stanford University.

Two NYU Langone Health Faculty Elected to National Academy of Medicine

Retrieved on: 
Tuesday, October 24, 2023
Knowledge, National Academies of Sciences, Engineering, and Medicine, COVID-19 Advisory Board, Policy, National Academy of Medicine, University of Washington Department of Global Health, Education, Coalition to Stop Gun Violence, Health, Internal medicine, Mathematics, University, Public health, STEMM, NYU Langone Health, Department of Medicine – University of Pamplona, Johns Hopkins Bloomberg School of Public Health, Kidney, Research, Observation, NYU, News, CBS News, COVID, Division, National academy, COVID-19, Institute of Medicine, Nepal, Doctor of Philosophy, New York University Grossman School of Medicine, SCM, Transplant, Public, Infection, Immunology, Communication, Pharmaceutical industry, Dentistry, Engineering, MD, Medicine, Science

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- Céline R. Gounder, MD, ScM , and Robert Montgomery, MD, DPhil , two innovators at NYU Langone, have been elected to the National Academy of Medicine, one of the highest honors in their field.

Key Points: 
  • NEW YORK, Oct. 24, 2023 /PRNewswire/ -- Céline R. Gounder, MD, ScM , and Robert Montgomery, MD, DPhil , two innovators at NYU Langone, have been elected to the National Academy of Medicine, one of the highest honors in their field.
  • In a statement, the academy recognized her "for being one of the world's leading experts in communication about science, medicine, and public health.
  • Dr. Montgomery, is the H. Leon Pachter, MD, Professor of Surgery, chair of the Department of Surgery at NYU Grossman School of Medicine, and director of the NYU Langone Transplant Institute .
  • The academy addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors.

Zymeworks Announces New Director Nominee

Retrieved on: 
Monday, October 16, 2023
Gene expression, Cancer, Internal medicine, Biology, Breast cancer, AACR, Apoptosis, Society, Cyber Security Collaborative Research Alliance, IND, University of Washington Department of Global Health, Fred Hutchinson Cancer Research Center, University, National Cancer Institute, Wellesley College, Disease, Hormone, Johns Hopkins Hospital, American Association for Cancer Research, Johns Hopkins, Harvard Medical School, Publication, Executive, ASCO, Molecular biology, Woman, Patient, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Pharmaceutical industry, MD, Zymeworks

“With this in mind, we are delighted to invite Dr. Davidson to join our board of directors.

Key Points: 
  • “With this in mind, we are delighted to invite Dr. Davidson to join our board of directors.
  • Her lab studies have paved the way for new clinical trials of drugs that exploit these pathways to kill breast cancer.
  • Prior to joining FHCC, she spent time at the National Cancer Institute, Johns Hopkins in Baltimore and the University of Pittsburgh.
  • Dr. Davidson completed her residency in Internal Medicine at John Hopkins Hospital and a fellowship at the National Cancer Institute.

Atomwise Announces Nomination of its First AI-Driven Development Candidate Focused on TYK2 Inhibition and Appoints Neely Mozaffarian, MD, PhD as Chief Medical Officer

Retrieved on: 
Tuesday, October 3, 2023
Other Health, Software, Research, Pharmaceutical, Data Management, Technology, Genetics, Clinical Trials, Science, Biotechnology, Other Science, Health, Lupus, Psoriatic arthritis, University, Deep learning, Multimedia, CMO, Doctor of Philosophy, Psoriasis, Inflammatory bowel disease, MD, Patient, University of Washington Department of Global Health, TYK2, Internal medicine, Drug discovery, AI, Albert Einstein College of Medicine, IND, Pharmaceutical industry, Rheumatology

Atomwise , a leader in using AI for small molecule drug discovery, today announced the nomination of its first AI-driven development candidate focused on TYK2 inhibition and the appointment of Neely Mozaffarian, MD, PhD as Chief Medical Officer.

Key Points: 
  • Atomwise , a leader in using AI for small molecule drug discovery, today announced the nomination of its first AI-driven development candidate focused on TYK2 inhibition and the appointment of Neely Mozaffarian, MD, PhD as Chief Medical Officer.
  • Dr. Mozaffarian brings over 25 years of immunology and clinical research experience to the role of Chief Medical Officer at Atomwise.
  • View the full release here: https://www.businesswire.com/news/home/20230927754050/en/
    Dr. Mozaffarian will drive Atomwise’s first development candidate, an orally bioavailable and allosteric TYK2 inhibitor discovered by leveraging Atomwise’s proprietary AI drug discovery platform AtomNet®, into clinical trials.
  • TYK2 is a key mediator in cytokine signaling pathways linked to a broad range of immune-mediated inflammatory conditions.

Celcuity to Host Virtual Science Day for Investors

Retrieved on: 
Thursday, September 7, 2023
University, MOA, Senior, Hematology, University of Washington Department of Global Health, Phase 3, Breast, Patient, Breast cancer, Division, CELC, Maghreb Virtual Science Library, Webcast, Institut Gustave Roussy, Oncology, Fred Hutchinson Cancer Research Center, UCLA, Gustav, Disease, Prostate cancer, Pharmaceutical industry, Medical imaging

ET on September 21, 2023

Key Points: 
  • ET on September 21, 2023
    MINNEAPOLIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will host a Virtual Science Day for analysts and investors from 10:00 a.m. – 12:00 p.m.
  • In early 2024, Celcuity expects to initiate the Phase 1b/2 CELC-G-201 trial of gedatolisib in combination with the androgen receptor inhibitor Nubeqa® (darolutamide) in metastatic castration resistant prostate cancer.
  • Celcuity’s Virtual Science Day for analysts and investors will take place on Thursday, September 21, 2023, from 10:00 a.m. to 12:00 p.m.
  • A replay of the webcast will be available on the “Events & Presentations” section of Celcuity’s website following the event.

King County Honors National Suicide Prevention Awareness Month with Countywide Suicide Prevention Week of Action

Retrieved on: 
Thursday, September 7, 2023
Mental Health, Health, Public Safety, State, Local, Public Policy, Government, Learning, University, ALL, Suicide, DCHS, National Suicide Prevention Week, QPR, Ask, Community, University of Washington Department of Global Health, Research, Question, Mental health, Residential care

September is National Suicide Prevention Awareness Month, and this year the King County Behavioral Health and Recovery Division, Department of Community and Human Services (DCHS), is encouraging community advocates to get involved in the Suicide Prevention Week of Action, September 10-16.

Key Points: 
  • September is National Suicide Prevention Awareness Month, and this year the King County Behavioral Health and Recovery Division, Department of Community and Human Services (DCHS), is encouraging community advocates to get involved in the Suicide Prevention Week of Action, September 10-16.
  • The initiative aims to bring together mental health and suicide prevention advocates in King County and equip them with tools and information to hold educational Suicide Prevention Week of Action events in their community.
  • The goal of these events is to collectively raise awareness and provide caring adults with youth suicide prevention strategies, including learning how to use the Ask, Listen, and Learn (ALL) conversation model.
  • (QPR), LEARN Saves Lives (from Forefront Suicide Prevention at the University of Washington), and Youth Mental Health First Aid.

AMERICAN BATTERY FACTORY NAMES AWARD-WINNING DR. JUN LIU CHIEF SCIENTIST

Retrieved on: 
Tuesday, September 5, 2023
CESR, Pacific Northwest National Laboratory, PNNL, University, ABF, ECS, CINT, Electrochemical Society, Institute of World Economy and International Relations, Lead, Integrative Center for Homeland Security, Research, International Coalition of Girls' Schools, Cell, LFP, DOE, Chemistry, Innovation Center station, Skolkovo Innovation Center, University of Washington Department of Global Health, Clarivate, Quality control, Mobile phone, Electric battery, Primary energy

AMERICAN FORK, Utah, Sept. 5, 2023 /PRNewswire/ -- American Battery Factory Inc. (ABF), an emerging battery manufacturer leading the development of the first network of lithium iron phosphate (LFP) battery cell gigafactories in the United States, today announced it has hired Dr. Jun Liu as the company's chief scientist to lead and support all aspects of ABF's research and development. In addition to his role at ABF, Liu serves as the director for the Innovation Center for the Battery500 Consortium, Washington Research Foundation Innovation Chair in Clean Energy, Campbell Chair of Materials Science & Engineering and Battelle Fellow at the Pacific Northwest National Laboratory (PNNL).

Key Points: 
  • "Dr. Liu brings a wealth of industry knowledge and exceptional experience to American Battery Factory, perfect for leading the development of our unique battery technology as we begin our network of gigafactories here in the United States," said Jim Ge, CEO of American Battery Factory.
  • At ABF, Liu will lead and support all aspects of the company's research and development from start to finish.
  • In his new role as ABF's chief scientist, he brings in-depth expertise in materials synthesis, characterization and application of advanced materials for energy.
  • "ABF's mission to develop a domestic supply chain for LFP batteries allows us to truly make energy independence a reality for everyone," said Dr. Jun Liu, chief scientist at American Battery Factory.

ReproTech LLC Appoints Brad Senstra Chief Executive Officer

Retrieved on: 
Tuesday, August 29, 2023
Women, Medical Supplies, Men, General Health, Health, Parenting, Consumer, Other Health, Industrial engineering, Reproductive medicine, SRM, University, American Society for Reproductive Medicine, Premera Blue Cross, Master of Health Administration, Virginia Mason Medical Center, Fertility clinic, Patient, University of Washington Department of Global Health, Fertility, Growth, Entrepreneurship, Transport, Society, Safety, Master, Management, Medical imaging

ReproTech LLC (“ReproTech” or the “Company”), the industry leader in human reproductive tissue cryogenic storage, today announced that Brad Senstra has been appointed Chief Executive Officer.

Key Points: 
  • ReproTech LLC (“ReproTech” or the “Company”), the industry leader in human reproductive tissue cryogenic storage, today announced that Brad Senstra has been appointed Chief Executive Officer.
  • A pioneer in dedicated reproductive storage with over 30 years of experience, ReproTech specializes in long-term cryostorage and safe transportation of reproductive tissues.
  • Mr. Senstra brings to ReproTech more than 16-years of experience in fertility and reproductive medicine.
  • Prior to joining the Company, he served as Executive Director of Seattle Reproductive Medicine (“SRM”).

NeuroFlow Ushers in New Era of Integrated Care to Support Sustainable Behavioral Health Management

Retrieved on: 
Tuesday, August 29, 2023
Software as a service, University, Face, BH, Research, Atlantic Health System, Acos, Organization, Patient, University of Washington Department of Global Health, Faculty, MPH, Mental health, Support, Nursing, MD

PHILADELPHIA, Aug. 29, 2023 /PRNewswire-PRWeb/ -- NeuroFlow, the market leading behavioral health SaaS platform, has announced a new tech-enabled approach to psychiatric collaborative care (CoCM), 'CoCM 2.0,' that combines the company's AI-driven analytics, care collaboration enablement, and enterprise consumer-grade activation. NeuroFlow's 'CoCM 2.0' approach builds on the traditional model's foundational registry requirement with three key advancements that transform how organizations deliver care and capture value:

Key Points: 
  • NeuroFlow monitors well-being after graduation, offering ongoing visibility for care teams and interventions to prevent deterioration
    NeuroFlow's health system customers are seeing results with improved outcomes while increasing revenue opportunities through the delivery of evidence-based care.
  • The automated population risk stratification in combination with the ability to integrate into care management and clinical workflows increases caseload capacity by nearly 36-40% annually.
  • All of this is done while achieving a 90% satisfaction rate among care teams, supporting reduction in clinical burnout.
  • NeuroFlow is used by evolvedMD , Magellan Healthcare , Emory Health, Ascension , Novant Health , and ACOs like Atlantic Health to support, among other initiatives, the execution of their collaborative care programs and services.

Marler Clark Files First Lawsuit in Salmonella Outbreak Linked to Papa Murphy's Cookie Dough

Retrieved on: 
Friday, August 18, 2023
Infection, Reactive arthritis, Food, Hip, Irritable bowel syndrome, Diarrhea, Food industry, Chills, Fever, University of Washington Department of Global Health, Chocolate chip cookie, Emergency department, Salmonellosis, Multimedia, Irritation, Sepsis, CDC, Vomiting, Poisoning, IBS, Papa Murphy's, Nausea, Salmonella, Bacteria, Rest, Fast food, Netflix

SEATTLE, Aug. 18, 2023 /PRNewswire/ -- Today Marler Clark filed a Salmonella lawsuit against Papa Murphy's , representing Michael Williams and Renee Sanders who were victims of an outbreak linked to Chocolate Chip Cookie and S'mores Bar dough.

Key Points: 
  • SEATTLE, Aug. 18, 2023 /PRNewswire/ -- Today Marler Clark filed a Salmonella lawsuit against Papa Murphy's , representing Michael Williams and Renee Sanders who were victims of an outbreak linked to Chocolate Chip Cookie and S'mores Bar dough.
  • In response to this investigation, Papa Murphy's notified franchise owners nationwide and stopped selling all Chocolate Chip Cookie dough and S'mores Bars dough at all stores.
  • They shared the pizza at a family gathering and stored the cookie dough.
  • The Salmonella lawyers of Marler Clark have represented thousands of victims of Salmonella and other foodborne illness outbreaks and have recovered over $850 million for clients.